BioWorld

Dec. 16, 1994

View Archived Issues

APPLIED IMMUNE SCIENCES BEGINS PHASE III OF EX VIVO CELL THERAPY FOR

Read More

OTHER NEWS TO NOTE

Read More

INDUSTRY APPLAUDS FASB DECISION TO DROP STOCK OPTION PROPOSAL

Read More

PROCYTE DOES NOT RESPOND TO SCHERER HEALTHCARE'S OFFER

Read More

MICE MISSING TNF RECEPTOR OFFER SEPSIS ANIMAL MODEL

Read More

TELIOS WITHDRAWS TENDER OFFER, CEO RESIGNS

Read More

DNA-MATCHING PINS AIDS-RELATED KAPOSI'S SARCOMA ON HERPESVIRUS

Read More

FBI FOILS BIOTECH INDUSTRIAL ESPIONAGE PLOT

Read More